[HTML][HTML] ABC transporters affects tumor immune microenvironment to regulate cancer immunotherapy and multidrug resistance

J Fan, KKW To, ZS Chen, L Fu - Drug Resistance Updates, 2023 - Elsevier
Multidrug resistance (MDR) is the phenomenon in which cancer cells simultaneously
develop resistance to a broad spectrum of structurally and mechanistically unrelated drugs …

Interleukin-8: A chemokine at the intersection of cancer plasticity, angiogenesis, and immune suppression

K Fousek, LA Horn, C Palena - Pharmacology & therapeutics, 2021 - Elsevier
Tumor progression relies on the ability of cancer cells to effectively invade surrounding
tissues and propagate. Among the many mechanisms that contribute to tumor progression is …

DRESIS: the first comprehensive landscape of drug resistance information

X Sun, Y Zhang, H Li, Y Zhou, S Shi… - Nucleic acids …, 2023 - academic.oup.com
Widespread drug resistance has become the key issue in global healthcare. Extensive
efforts have been made to reveal not only diverse diseases experiencing drug resistance …

Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons

M Akman, DC Belisario, IC Salaroglio… - Journal of Experimental …, 2021 - Springer
Solid tumors often grow in a micro-environment characterized by< 2% O 2 tension. This
condition, together with the aberrant activation of specific oncogenic patwhays, increases …

Drug resistance and Cancer stem cells

Y Li, Z Wang, JA Ajani, S Song - Cell Communication and Signaling, 2021 - Springer
Therapy resistance is a major problem when treating cancer patients as cancer cells
develop mechanisms that counteract the effect of therapeutic compounds, leading to fit and …

Hypoxia dictates metabolic rewiring of tumors: implications for chemoresistance

DC Belisario, J Kopecka, M Pasino, M Akman… - Cells, 2020 - mdpi.com
Hypoxia is a condition commonly observed in the core of solid tumors. The hypoxia-
inducible factors (HIF) act as hypoxia sensors that orchestrate a coordinated response …

Drug resistance in osteosarcoma: emerging biomarkers, therapeutic targets and treatment strategies

CM Hattinger, MP Patrizio, L Fantoni, C Casotti… - Cancers, 2021 - mdpi.com
Simple Summary Despite the adoption of aggressive, multimodal treatment schedules, the
cure rate of high-grade osteosarcoma (HGOS) has not significantly improved in the last 30 …

Cancer-associated fibroblast-induced lncRNA UPK1A-AS1 confers platinum resistance in pancreatic cancer via efficient double-strand break repair

X Zhang, S Zheng, C Hu, G Li, H Lin, R Xia, Y Ye, R He… - Oncogene, 2022 - nature.com
The tumor stroma of pancreatic ductal adenocarcinoma (PDAC) is characterized by an
abundant and heterogeneous population of cancer-associated fibroblasts (CAFs), which are …

Huaier suppresses cisplatin resistance in non-small cell lung cancer by inhibiting the JNK/JUN/IL-8 signaling pathway

H Jin, C Liu, X Liu, H Wang, Y Zhang, Y Liu, J Li… - Journal of …, 2024 - Elsevier
Abstract Ethnopharmacological relevance Huaier (Trametes robiniophila Murr), a traditional
Chinese medicinal fungus, possesses potent anticancer efficacy and has been used as an …

IL-1β is involved in docetaxel chemoresistance by regulating the formation of polyploid giant cancer cells in non-small cell lung cancer

S Zhao, S Xing, L Wang, M Ouyang, S Liu, L Sun… - Scientific Reports, 2023 - nature.com
Docetaxel (Doc) is a cornerstone of chemotherapy; however, treatment with Doc often and
inevitably leads to drug resistance and the formation of polyploid giant cancer cells …